Precision medicine is increasingly being used in radiological applications. Advanced machine learning coupled with informatics modeling of clinical and radiological variables can provide the foundation to relate to precision medicine in patients with prostate cancer. We test our modeling using multiparametric prostate MR imaging (mpMRI) and MR-guided prostate biopsy with magnetic resonance-transrectal ultrasound (MR-TRUS) fusion to correlate the imaging features with histopathological results.
This abstract and the presentation materials are available to members only; a login is required.